{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:23:58Z","timestamp":1791404638646,"version":"4.3.3"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011698","name":"Junta de Comunidades de Castilla-La Mancha","doi-asserted-by":"publisher","award":["SBPLY\/21\/180501\/000150"],"award-info":[{"award-number":["SBPLY\/21\/180501\/000150"]}],"id":[{"id":"10.13039\/501100011698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007480","name":"Universidad de Castilla-La Mancha","doi-asserted-by":"publisher","award":["2023-PRED-21780"],"award-info":[{"award-number":["2023-PRED-21780"]}],"id":[{"id":"10.13039\/501100007480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007480","name":"Universidad de Castilla-La Mancha","doi-asserted-by":"publisher","award":["2021-MS-20549"],"award-info":[{"award-number":["2021-MS-20549"]}],"id":[{"id":"10.13039\/501100007480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SBPLY\/21\/180501\/000150"],"award-info":[{"award-number":["SBPLY\/21\/180501\/000150"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2022-GRIN-34354"],"award-info":[{"award-number":["2022-GRIN-34354"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020\\u2013115823-GBI00"],"award-info":[{"award-number":["PID2020\\u2013115823-GBI00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118247","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T18:14:06Z","timestamp":1749838446000},"page":"118247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["VU0810464, a selective GIRK channel activator, improves hippocampal-dependent synaptic plasticity and memory disrupted by amyloid-\u03b2 oligomers"],"prefix":"10.1016","volume":"189","author":[{"given":"Jaime","family":"Mulero-Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8755-0392","authenticated-orcid":false,"given":"Raquel","family":"Jimenez-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2185-0851","authenticated-orcid":false,"given":"Ana","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8044-6461","authenticated-orcid":false,"given":"Souhail","family":"Djebari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Jim\u00e9nez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Navarro-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.biopha.2025.118247_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2025.118247_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2025.118247_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CLEP.S37929","article-title":"Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences","volume":"6","author":"Mielke","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.biopha.2025.118247_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer's disease: a systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res Rev."},{"issue":"11","key":"10.1016\/j.biopha.2025.118247_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118247_bib6","first-page":"748","article-title":"Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition","volume":"140","author":"Pontecorvo","year":"2017","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.biopha.2025.118247_bib7","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ajpath.2017.03.011","article-title":"Enhanced tau aggregation in the presence of amyloid beta","volume":"187","author":"Bennett","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118247_bib8","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0488-23.2023","article-title":"Spatiotemporal correlation between amyloid and tau accumulations underlies cognitive changes in aging","volume":"44","author":"Kim","year":"2024","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"12","key":"10.1016\/j.biopha.2025.118247_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118247_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jnc.15007","article-title":"A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Abeta oligomers from Alzheimer's brain","volume":"154","author":"Li","year":"2020","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.biopha.2025.118247_bib12","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1038\/s41380-022-01589-5","article-title":"Bioactive human Alzheimer brain soluble Abeta: pathophysiology and therapeutic opportunities","volume":"27","author":"Li","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","article-title":"Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?","volume":"12","author":"Dias Anastacio","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2025.118247_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112152","article-title":"Aberrant serotonergic signaling contributes to the hyperexcitability of CA1 pyramidal neurons in a mouse model of Alzheimer's disease","volume":"42","author":"Wang","year":"2023","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15306-8","article-title":"Activation of G-protein-gated inwardly rectifying potassium (Kir3\/GirK) channels rescues hippocampal functions in a mouse model of early amyloid-\u03b2 pathology","volume":"7","author":"S\u00e1nchez-Rodr\u00edguez","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118247_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-neuro-080317-061725","article-title":"What happens with the circuit in Alzheimer's Disease in mice and humans?","volume":"41","author":"Zott","year":"2018","journal-title":"Annu Rev. Neurosci."},{"key":"10.1016\/j.biopha.2025.118247_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107808","article-title":"Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system","volume":"223","author":"Jeremic","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118247_bib18","doi-asserted-by":"crossref","first-page":"C439","DOI":"10.1152\/ajpcell.00102.2022","article-title":"Neuronal G protein-gated K(+) channels","volume":"323","author":"Luo","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"33","key":"10.1016\/j.biopha.2025.118247_bib19","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.1523\/JNEUROSCI.2849-20.2021","article-title":"G-protein-gated inwardly rectifying potassium (Kir3\/GIRK) channels govern synaptic plasticity that supports hippocampal-dependent cognitive functions in male mice","volume":"41","author":"Djebari","year":"2021","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118247_bib20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.biopsych.2015.10.004","article-title":"G protein-gated K+ channel ablation in forebrain pyramidal neurons selectively impairs fear learning","volume":"80","author":"Victoria","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2025.118247_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1113\/JP280434","article-title":"Reduced activity of GIRK1-containing heterotetramers is sufficient to affect neuronal functions, including synaptic plasticity and spatial learning and memory","volume":"599","author":"Mett","year":"2021","journal-title":"J. Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118247_bib22","doi-asserted-by":"crossref","DOI":"10.1101\/lm.054022.124","article-title":"Domain-selective and sex-dependent regulation of learning and memory in mice by GIRK channel activity in CA1 pyramidal neurons of the dorsal hippocampus","volume":"31","author":"Luo","year":"2024","journal-title":"Learn Mem."},{"key":"10.1016\/j.biopha.2025.118247_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fncel.2013.00117","article-title":"Amyloid-\u03b2 induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse","volume":"7","author":"Nava-Mesa","year":"2013","journal-title":"Front. Cell Neurosci."},{"issue":"15","key":"10.1016\/j.biopha.2025.118247_bib24","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1523\/JNEUROSCI.5312-04.2005","article-title":"Constitutively active G-protein-gated inwardly rectifying K+ channels in dendrites of hippocampal CA1 pyramidal neurons","volume":"25","author":"Chen","year":"2005","journal-title":"J. Neurosci."},{"issue":"14","key":"10.1016\/j.biopha.2025.118247_bib25","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1523\/JNEUROSCI.2784-16.2017","article-title":"Dendritic GIRK channels gate the integration window, plateau potentials, and induction of synaptic plasticity in dorsal but not ventral CA1 neurons","volume":"37","author":"Malik","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118247_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109668","article-title":"Impairments in hippocampal oscillations accompany the loss of LTP induced by GIRK activity blockade","author":"Contreras","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118247_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103531","article-title":"I(h), GIRK, and KCNQ\/Kv7 channels differently modulate sharp wave - ripples in the dorsal and ventral hippocampus","volume":"107","author":"Trompoukis","year":"2020","journal-title":"Mol. Cell Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118247_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tips.2020.12.002","article-title":"Advances in targeting GIRK channels in disease","volume":"42","author":"Zhao","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118247_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/jnc.14946","article-title":"Hippocampal long-term synaptic depression and memory deficits induced in early amyloidopathy are prevented by enhancing G-protein-gated inwardly rectifying potassium channel activity","volume":"153","author":"S\u00e1nchez-Rodr\u00edguez","year":"2020","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118247_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051168","article-title":"Role of GirK channels in long-term potentiation of synaptic inhibition in an in vivo mouse model of early amyloid-\u03b2 pathology","volume":"20","author":"S\u00e1nchez-Rodr\u00edguez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.biopha.2025.118247_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011106","article-title":"The expression and localisation of G-protein-coupled inwardly rectifying potassium (GIRK) channels is differentially altered in the hippocampus of two mouse models of Alzheimer's Disease","volume":"22","author":"Alfaro-Ruiz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.biopha.2025.118247_bib32","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.18632\/aging.104026","article-title":"GIRK channels in Alzheimer's disease","volume":"12","author":"Lieberman","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13195-022-01078-5","article-title":"Nanoscale alterations in GABA(B) receptors and GIRK channel organization on the hippocampus of APP\/PS1 mice","volume":"14","author":"Martin-Belmonte","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.biopha.2025.118247_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fnins.2017.00455","article-title":"G-protein-coupled inwardly rectifying potassium (GIRK) channel activation by the p75 neurotrophin receptor is required for amyloid beta toxicity","volume":"11","author":"May","year":"2017","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118247_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134385","article-title":"Amyloid-\u03b2(25-35) modulates the expression of GirK and KCNQ channel genes in the hippocampus","volume":"10","author":"Mayordomo-Cava","year":"2015","journal-title":"PLoS One"},{"issue":"856","key":"10.1016\/j.biopha.2025.118247_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.ado4132","article-title":"Amyloid-beta oligomers trigger sex-dependent inhibition of GIRK channel activity in hippocampal neurons in mice","volume":"17","author":"Luo","year":"2024","journal-title":"Sci. Signal"},{"key":"10.1016\/j.biopha.2025.118247_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117914","article-title":"Social and contextual memory impairments induced by Amyloid-beta oligomers are rescued by Sigma-1 receptor activation","volume":"184","author":"Djebari","year":"2025","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13293-023-00545-4","article-title":"Systematic characterization of a non-transgenic Abeta(1-42) amyloidosis model: synaptic plasticity and memory deficits in female and male mice","volume":"14","author":"Jimenez-Herrera","year":"2023","journal-title":"Biol. Sex. Differ."},{"issue":"9","key":"10.1016\/j.biopha.2025.118247_bib39","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1021\/acschemneuro.7b00217","article-title":"Discovery and characterization of 1H-pyrazol-5-yl-2-phenylacetamides as novel, non-urea-containing GIRK1\/2 potassium channel activators","volume":"8","author":"Wieting","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118247_bib40","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biopha.2025.118247_bib41","series-title":"The Mouse in Biomedical Research (Second Edition)","first-page":"637","article-title":"Chapter 20 - Mouse Models in Aging Research","author":"Flurkey","year":"2007"},{"issue":"75","key":"10.1016\/j.biopha.2025.118247_bib42","doi-asserted-by":"crossref","DOI":"10.3791\/50326-v","article-title":"Direct intraventricular delivery of drugs to the rodent central nervous system","author":"DeVos","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2025.118247_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2016.08.002","article-title":"Early effects of Abeta1-42 oligomers injection in mice: involvement of PI3K\/Akt\/GSK3 and MAPK\/ERK1\/2 pathways","volume":"314","author":"Morroni","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.biopha.2025.118247_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221563","article-title":"Amyloid \u03b2 oligomers inhibit growth of human cancer cells","volume":"14","author":"Pavliukeviciene","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2025.118247_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1021\/acschemneuro.0c00642","article-title":"Characterization of homogeneous and heterogeneous amyloid-\u03b242 oligomer preparations with biochemical methods and infrared spectroscopy reveals a correlation between infrared spectrum and oligomer size","volume":"12","author":"Vosough","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"13","key":"10.1016\/j.biopha.2025.118247_bib46","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1111\/bph.14671","article-title":"VU0810464, a non-urea G protein-gated inwardly rectifying K(+) (K(ir) 3\/GIRK) channel activator, exhibits enhanced selectivity for neuronal K(ir) 3 channels and reduces stress-induced hyperthermia in mice","volume":"176","author":"Vo","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118247_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105939","article-title":"Degenerate mapping of environmental location presages deficits in object-location encoding and memory in the 5xFAD mouse model for Alzheimer's disease","volume":"176","author":"Zhang","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2025.118247_bib48","article-title":"Posterior parietal cortex oscillatory activity shapes persistent spatial memory impairments induced by soluble amyloid-\u03b2 oligomers","author":"Djebari","year":"2023","journal-title":"Res. Sq. (Prepr.)"},{"issue":"49","key":"10.1016\/j.biopha.2025.118247_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208254119","article-title":"Spatial contextual recognition memory updating is modulated by dopamine release in the dorsal hippocampus from the locus coeruleus","volume":"119","author":"Galvez-Marquez","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118247_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41514-017-0013-z","article-title":"How does hormesis impact biology, toxicology, and medicine?","volume":"3","author":"Calabrese","year":"2017","journal-title":"NPJ Aging Mech. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2025.118247_bib51","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nn.4101","article-title":"Resolving the neural circuits of anxiety","volume":"18","author":"Calhoon","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"29","key":"10.1016\/j.biopha.2025.118247_bib52","doi-asserted-by":"crossref","first-page":"10755","DOI":"10.1073\/pnas.1405190111","article-title":"Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297","volume":"111","author":"Wydeven","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.biopha.2025.118247_bib53","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118247_bib54","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1210\/en.2012-1340","article-title":"Minireview: translational animal models of human menopause: challenges and emerging opportunities","volume":"153","author":"Brinton","year":"2012","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.biopha.2025.118247_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.14283\/jpad.2018.34","article-title":"Female sex and Alzheimer's risk: the menopause connection","volume":"5","author":"Scheyer","year":"2018","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.biopha.2025.118247_bib56","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","article-title":"Sex differences in Alzheimer's disease and common neuropathologies of aging","volume":"136","author":"Oveisgharan","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118247_bib57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer's disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118247_bib58","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity: a randomized clinical trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib59","article-title":"The HOPE4MCI study: a randomized double-blind assessment of AGB101 for the treatment of MCI due to AD","volume":"10","author":"Mohs","year":"2024","journal-title":"Alzheimers Dement (N. Y.)"},{"key":"10.1016\/j.biopha.2025.118247_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114545","article-title":"Low dose of levetiracetam counteracts amyloid beta-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity","volume":"369","author":"Isla","year":"2023","journal-title":"Exp. Neurol."},{"issue":"42","key":"10.1016\/j.biopha.2025.118247_bib61","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118247_bib62","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2018.02.029","article-title":"Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer's disease","volume":"98","author":"Martinez-Losa","year":"2018","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.biopha.2025.118247_bib64","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/bies.201500004","article-title":"Neuronal hyperactivity--a key defect in Alzheimer's disease?","volume":"37","author":"Busche","year":"2015","journal-title":"Bioessays"},{"key":"10.1016\/j.biopha.2025.118247_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101372","article-title":"Neuronal excitation\/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology","volume":"69","author":"Maestu","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2025.118247_bib66","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/cn400062a","article-title":"ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice","volume":"4","author":"Kaufmann","year":"2013","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118247_bib67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0024-3205(91)90537-L","article-title":"The utility of 2-hydroxypropyl-beta-cyclodextrin as a vehicle for the intracerebral and intrathecal administration of drugs","volume":"48","author":"Yaksh","year":"1991","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118247_bib68","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2025.118247_bib69","series-title":"The Hippocampus Book","first-page":"343","article-title":"Synaptic Plasticity in the Hippocampus","author":"Bliss","year":"2007"},{"issue":"2","key":"10.1016\/j.biopha.2025.118247_bib70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1113\/jphysiol.1973.sp010273","article-title":"Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path","volume":"232","author":"Bliss","year":"1973","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2025.118247_bib71","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nbd.2015.10.019","article-title":"Soluble Abeta oligomers impair hippocampal LTP by disrupting glutamatergic\/GABAergic balance","volume":"85","author":"Lei","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbr.2009.06.005","article-title":"Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation","volume":"204","author":"Assini","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118247_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2008.05.021","article-title":"D(1) dopaminergic control of G protein-dependent inward rectifier K(+) (GIRK)-like channel current in pyramidal neurons of the medial prefrontal cortex","volume":"155","author":"Witkowski","year":"2008","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.biopha.2025.118247_bib74","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3233\/JAD-221197","article-title":"Epileptic prodromal Alzheimer's disease treated with antiseizure medications: medium-term outcome of seizures and cognition","volume":"94","author":"Hautecloque-Raysz","year":"2023","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118247_bib75","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3233\/JAD-230613","article-title":"Putting the brakes on accelerated cognitive decline in Alzheimer's disease with epileptic activity","volume":"94","author":"Vossel","year":"2023","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118247_bib76","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0896-6273(00)80102-6","article-title":"Ca2+ signaling requirements for long-term depression in the hippocampus","volume":"16","author":"Cummings","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118247_bib77","doi-asserted-by":"crossref","DOI":"10.2196\/68454","article-title":"Clinical benefits and risks of antiamyloid antibodies in sporadic Alzheimer disease: systematic review and network meta-analysis with a web application","volume":"27","author":"Jeremic","year":"2025","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.biopha.2025.118247_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102003","article-title":"Targeting epigenetics: a novel promise for Alzheimer's disease treatment","volume":"90","author":"Jeremic","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biopha.2025.118247_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102012","article-title":"Efficacy and safety of anti-amyloid-beta monoclonal antibodies in current Alzheimer's disease phase III clinical trials: a systematic review and interactive web app-based meta-analysis","volume":"90","author":"Jeremic","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biopha.2025.118247_bib80","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2023.5684","article-title":"Diagnosing preclinical and prodromal neurodegenerative diseases-the clinical is political","author":"Erickson","year":"2024","journal-title":"JAMA Neurol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500441X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500441X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:01:23Z","timestamp":1762311683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500441X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":80,"alternative-id":["S075333222500441X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118247","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VU0810464, a selective GIRK channel activator, improves hippocampal-dependent synaptic plasticity and memory disrupted by amyloid-\u03b2 oligomers","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118247"}}